The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The validation of surrogate endpoints in meta-analyses of randomized experiments
Open accessAbstract
The validation of surrogate endpoints has been studied by Prentice (1989). He presented a definition as well as a set of criteria, which are equivalent only if the surrogate and true endpoints are binary. Freedman et al. (1992) supplemented these criteria with the so-called 'proportion explained'. Buyse and Molenberghs (1998) proposed replacing the proportion explained by two quantities: (1) the relative effect linking the effect of treatment on both endpoints and (2) an individual-level measure of agreement between both endpoints. The latter quantity carries over when data are available on several randomized trials, while the former can be extended to be a trial-level measure of agreement between the effects of treatment of both endpoints. This approach suggests a new method for the validation of surrogate endpoints, and naturally leads to the prediction of the effect of treatment upon the true endpoint, given its observed effect upon the surrogate endpoint. These ideas are illustrated using data from two sets of multicenter trials: one comparing chemotherapy regimens for patients with advanced ovarian cancer, the other comparing interferon-alpha with placebo for patients with age-related macular degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Littell, R. C. (1996) · Medical Entomology and Zoology · Cited by 10,547
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
Approximate Inference in Generalized Linear Mixed Models
Breslow, N. E., & Clayton, D. G. (1993) · Journal of the American Statistical Association · doi:10.1080/01621459.1993.10594284 · Cited by 4,629
Models for Longitudinal Data: A Generalized Estimating Equation Approach
Zeger, S. L., Liang, K.-Y., & Albert, P. S. (1988) · Biometrics · doi:10.2307/2531734 · Cited by 4,505
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00003 · Cited by 2,067
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Surrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
Multivariate Statistical Modelling Based on Generalized Linear Models
Fahrmeir, L., & Tutz, G. (1994) · Springer Series in Statistics · doi:10.1007/978-1-4899-0010-4 · Cited by 1,391
Review papers : The statistical basis of meta-analysis
Fleiss, J. (1993) · Statistical Methods in Medical Research · doi:10.1177/096228029300200202 · Cited by 1,281
Generalized linear mixed models a pseudo-likelihood approach
Wolfinger, R., & O'connell, M. (1993) · Journal of Statistical Computation and Simulation · doi:10.1080/00949659308811554 · Cited by 1,271
Hierarchical Generalized Linear Models
Lee, Y., & Nelder, J. A. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02105.x · Cited by 970
Multivariate Regression Analyses for Categorical Data
Liang, K.-Y., Zeger, S. L., & Qaqish, B. (1992) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1992.tb01862.x · Cited by 761
Random-Effects Models for Serial Observations with Binary Response
Stiratelli, R., Laird, N., & Ware, J. H. (1984) · Biometrics · doi:10.2307/2531147 · Cited by 733
Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS
O'Brien, W. A., Hartigan, P. M., Martin, D., Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff, M. S., & Hamilton, J. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340703 · Cited by 720
Statistical validation of intermediate endpoints for chronic diseases
Freedman, L. S., Graubard, B. I., & Schatzkin, A. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110204 · Cited by 651
ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER
LIN, D. Y., FLEMING, T. R., & DE GRUTTOLA, V. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970715)16:13<1515::aid-sim572>3.0.co;2-1 · Cited by 520
Thompson, S. G., & Pocock, S. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91975-z · Cited by 487
Linear Mixed Models in Practice: A SAS-Oriented Approach
Lenth, R. V., Verbeke, G., & Molenberghs, G. (1998) · Journal of the American Statistical Association · doi:10.2307/2669875 · Cited by 485
Self-citationAnalysis of Longitudinal Data.
Diggle, P. J., Liang, K.-Y., & Zeger, S. L. (1997) · Biometrics · doi:10.2307/2533983 · Cited by 447
Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
Buyse, M., & Molenberghs, G. (1998) · Biometrics · doi:10.2307/2533853 · Cited by 425
Self-citationModelling Progression of CD4-Lymphocyte Count and Its Relationship to Survival Time
Gruttola, V. D., & Tu, X. M. (1994) · Biometrics · doi:10.2307/2533439 · Cited by 384
Meta-analysis for the evaluation of potential surrogate markers
Daniels, M. J., & Hughes, M. D. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970915)16:17<1965::aid-sim630>3.0.co;2-m · Cited by 362
A likelihood-based method for analysing longitudinal binary responses
FITZMAURICE, G. M., & LAIRD, N. M. (1993) · Biometrika · doi:10.1093/biomet/80.1.141 · Cited by 328
Glonek, G. F. V., & McCullagh, P. J. (1995) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.2517-6161.1995.tb02046.x · Cited by 321
Ziegel, E. R., Diggle, P., Liang, K., & Zeger, S. (1995) · Technometrics · doi:10.2307/1269941 · Cited by 321
Marginal Modeling of Correlated Ordinal Data Using a Multivariate Plackett Distribution
Molenberghs, G., & Lesaffre, E. (1994) · Journal of the American Statistical Association · doi:10.1080/01621459.1994.10476788 · Cited by 292
Self-citationSimultaneously Modeling Joint and Marginal Distributions of Multivariate Categorical Responses
Lang, J. B., & Agresti, A. (1994) · Journal of the American Statistical Association · doi:10.1080/01621459.1994.10476787 · Cited by 264
Choi, S., Lagakos, S. W., Schooley, R. T., & Volberding, P. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00003 · Cited by 190
Fleming, T. R., Prentice, R. L., Pepe, M. S., & Glidden, D. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130906 · Cited by 167
Surrogate endpoints: A basis for a rational approach
Boissel, J. P., Collet, J. P., Moleur, P., & Haugh, M. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02333016 · Cited by 166
Surrogate endpoints in clinical trials: Cancer
Ellenberg, S. S., & Hamilton, J. M. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080404 · Cited by 166
Controversies in meta-analysis: the case of the trials of serum cholesterol reduction
Thompson, S. G. (1993) · Statistical Methods in Medical Research · doi:10.1177/096228029300200205 · Cited by 118
Gruttola, V. D., Wulfsohn, M. S., Fischl, M. A., & Tsiatis, A. A. (1993) · PubMed · Cited by 110
Linear Mixed Models in Practice: A SAS-Oriented Approach (Lecture Notes in Statistics 126)
Stewart, P. W., Verbeke, G. N., & Molenberghs, G. (1999) · Technometrics · doi:10.2307/1271007 · Cited by 67
Self-citationChalmers, I., Stewart, L., Girling, D. J., Parmar, M. B., & Machin, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92771-s · Cited by 34
Linear mixed Models in practice a SAS oriented approach
Verbeke, G., & Molenberghs, G. (1997) · Cited by 26
Self-citationThe Value of Surrogate Endpoints for Evaluation of Therapeutic Efficacy
Weihrauch, T. R., & Demol, P. (1998) · Drug Information Journal · doi:10.1177/009286159803200313 · Cited by 3
Senn (1998) · doi:10.1002/(sici)1097-0258(19980815/30)17:15/16
Cited by
de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
Principal Stratification in Causal Inference
Frangakis, C. E., & Rubin, D. B. (2002) · Biometrics · doi:10.1111/j.0006-341x.2002.00021.x · Cited by 1,511
Sargent, D. J., Wieand, H. S., Haller, D. G., Gray, R., Benedetti, J. K., Buyse, M., Labianca, R., Seitz, J. F., O'Callaghan, C. J., Francini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6071 · Cited by 713
Recent developments in meta‐analysis
Sutton, A. J., & Higgins, J. P. T. (2008) · Statistics in Medicine · doi:10.1002/sim.2934 · Cited by 590
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
Xie, W., Regan, M. M., Buyse, M., Halabi, S., Kantoff, P. W., Sartor, O., Soule, H., Clarke, N. W., Collette, L., Dignam, J. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.9987 · Cited by 433
Self-citation
Metadata
- Authors
- Buyse, M., Molenberghs, G., Burzykowski, T., Renard, D., & Geys, H.
- Venue
- Biostatistics
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-03
- Volume
- 1
- Issue
- 1
- Pages
- 49-67
- ISSN
- 1465-4644 (ISSN-L)
- 1468-4357
- OpenAlex
- W2126133903
- Cited by
- 624
- References
- 40
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.